Strattera and Levoxyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Levoxyl (levothyroxine sodium). Common drug interactions include blood glucose increased among females and tremor among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Levoxyl. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

On Jul, 27, 2026

59 people who take Strattera and Levoxyl together, and have interactions are studied.

Strattera and Levoxyl drug interactions.

What are the common drug interactions of Strattera and Levoxyl, by gender? *:

female:

Blood glucose increased
Blood pressure increased
Blood urea decreased
Body temperature increased
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Depressed level of consciousness
Device dislocation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

Tremor (trembling or shaking movements in one or more parts of your body)
Dysuria (painful or difficult urination)
Genital discharge
Micturition disorder (disease of passing urine)
Prostatitis (inflammation of the prostate gland)
Abnormal behaviour
Alanine aminotransferase increased
Aspartate aminotransferase increased
Delayed delivery
Diabetes mellitus inadequate control

What are the common drug interactions of Strattera and Levoxyl, by age (0-1 to 60+)? *:

0-1:

Delayed delivery
Foetal heart rate decreased

2-9:

Drug ineffective
Heart rate increased
Weight decreased

10-19:

Abnormal behaviour
Aphagia (inability or refusal to swallow)
Blood glucose decreased
Diabetes mellitus inadequate control
Immune system disorder
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Somnolence (a state of near-sleep, a strong desire for sleep)
Type 2 diabetes mellitus

20-29:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Injury
Pain
Dizziness
Fatigue (feeling of tiredness)
Initial insomnia (feeling of inadequate or poor-quality sleep)

30-39:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Device dislocation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug ineffective
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dysmenorrhoea (painful menstruation)
Haematuria (presence of blood in urine)
Headache (pain in head)
Hyperventilation

40-49:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Penis disorder
Psychomotor hyperactivity (feelings of extreme restlessness)
Restlessness (not able to rest)
Rigors (an episode of shaking or exaggerated shivering)
Stomach discomfort (pain in abdomen)
Thirst
Urinary hesitation (difficulty in beginning the flow of urine)
Headache (pain in head)
Nausea (feeling of having an urge to vomit)

50-59:

Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscle contractions involuntary (uncontrolled muscle contraction)
Anxiety
Drug ineffective
Fatigue (feeling of tiredness)
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Nervousness
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dysuria (painful or difficult urination)

60+:

Abdominal distension
Ascites (accumulation of fluid in the abdominal cavity)
Mood swings (an extreme or rapid change in mood)
Nervousness
Pleural effusion (water on the lungs)
Polyuria (production of too much dilute urine)
Somnolence (a state of near-sleep, a strong desire for sleep)
Stress symptoms
Tension (the act or process of stretching something tight)
Vomiting

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 11.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.17%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 8.47%
Disturbance In Attention: 5 people, 8.47%
Depression: 5 people, 8.47%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 5.08%
Rapid Eye Movements Sleep Abnormal: 3 people, 5.08%
Parkinson's Disease: 3 people, 5.08%
Pain: 3 people, 5.08%
Memory Loss: 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Levoxyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously